Acorda Therapeutics Inc. (ACOR)
NASDAQ: ACOR
· Real-Time Price · USD
0.66
-0.21 (-24.14%)
At close: Apr 03, 2024, 3:59 PM
Acorda Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -27.39M | -217.76M | -8.89M | -9.38M | -16.82M | 19.14M | -13.85M | -46.68M | -24.52M | -20.57M | -27.07M | -22.86M | -33.45M |
Depreciation & Amortization | 882K | 7.92M | 7.92M | 7.91M | 7.91M | 8.04M | 7.79M | 8.44M | 8.53M | 8.47M | 8.32M | 8.63M | 8.53M |
Stock-Based Compensation | 130K | 138K | 141K | 128K | 71K | 173K | 364K | 471K | 485K | 480K | 854K | 954K | 707K |
Other Working Capital | n/a | -61K | -4.63M | -1.38M | 701K | 1.61M | 922K | -814K | -1.04M | 11.17M | 815K | 179K | 611K |
Other Non-Cash Items | 11.57M | 253.89M | -341K | 3.81M | 3.37M | -18.52M | -499K | -789K | -1.86M | 7.22M | 3.1M | -4.95M | 545K |
Deferred Income Tax | n/a | -38.16M | -1.02M | -1.97M | -2.04M | 2.37M | 1.42M | 26.63M | 258K | 1.6M | -3.1M | -531K | -3.15M |
Change in Working Capital | -5.37M | -9.05M | 9.8M | -12.06M | 486K | -2.13M | 2.94M | -2.58M | 3.47M | 6.04M | 8.89M | 10.07M | -64K |
Operating Cash Flow | -20.18M | -3.02M | 7.61M | -11.56M | -7.02M | 9.07M | -1.84M | -14.51M | -13.64M | 3.24M | -9.01M | -8.69M | -26.89M |
Capital Expenditures | n/a | -44K | -220K | n/a | n/a | 14K | -150K | -70K | -39K | -1K | n/a | -136K | -54K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | 109K | -123K | n/a | n/a | 73.97M | n/a | n/a | n/a |
Investing Cash Flow | n/a | -44K | -220K | n/a | n/a | 123K | -150K | -70K | -39K | 73.97M | n/a | -136K | -54K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | 6.88M | n/a | n/a | n/a | n/a | -1K | n/a | n/a | -73.97M | n/a | -69M | 73.31M |
Financial Cash Flow | n/a | 6.88M | -6.88M | n/a | n/a | 1K | -1K | n/a | n/a | -73.97M | n/a | -69M | 73.31M |
Net Cash Flow | -20.28M | -2.97M | 7.23M | -11.4M | -6.92M | 10.49M | -2.31M | -14.96M | -13.77M | 3.3M | -9.08M | -77.44M | 45.54M |
Free Cash Flow | -20.18M | -3.06M | 7.39M | -11.56M | -7.02M | 9.08M | -1.99M | -14.58M | -13.68M | 3.24M | -9.01M | -8.82M | -26.94M |